Psoriasis
Conditions
Keywords
psoriasis, systematic review, meta-analyses
Brief summary
This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints including the Physician Global Assessment (PGA), Dermatology Life Quality Index (DLQI), and Short-Form 36 (SF-36). A traditional meta-analysis and a mixed treatment comparison was conducted on the extracted data.
Detailed description
This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints including the Physician Global Assessment (PGA), Dermatology Life Quality Index (DLQI), and Short-Form 36 (SF-36). A traditional meta-analysis and a mixed treatment comparison was conducted on the extracted data. We included all published randomized controlled trials of treatments for moderate-to-severe psoriasis that met the study inclusion criteria.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Randomized controlled clinical trials of treatments for moderate-to-severe plaque psoriasis. * Trials had to evaluate at least one of the following: Physician's Global Assessment (PGA), Dermatology Life Quality Index (DLQI) and/or the Short-Form 36 (SF-36).
Exclusion criteria
Observational studies * Trials that did not report the Physician's Global Assessment (PGA), * Dermatology Life Quality Index (DLQI) or the Short-Form 36 (SF-36).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physician Global Assessment (PGA) | — |
| Dermatology Life Quality Index (DLQI) | — |
| Short-Form 36 (SF-36) | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes | No secondary outcomes |